ICFI vs. AMEH, MEG, RMR, HCKT, FCN, EXPO, DNB, CBZ, HURN, and VSEC
Should you be buying ICF International stock or one of its competitors? The main competitors of ICF International include Apollo Medical (AMEH), Montrose Environmental Group (MEG), The RMR Group (RMR), The Hackett Group (HCKT), FTI Consulting (FCN), Exponent (EXPO), Dun & Bradstreet (DNB), CBIZ (CBZ), Huron Consulting Group (HURN), and VSE (VSEC).
Apollo Medical (NASDAQ:AMEH) and ICF International (NASDAQ:ICFI) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, community ranking, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.
ICF International has higher revenue and earnings than Apollo Medical. ICF International is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.
Apollo Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, ICF International has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.
35.9% of Apollo Medical shares are held by institutional investors. Comparatively, 94.1% of ICF International shares are held by institutional investors. 8.5% of Apollo Medical shares are held by insiders. Comparatively, 1.4% of ICF International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, ICF International had 13 more articles in the media than Apollo Medical. MarketBeat recorded 15 mentions for ICF International and 2 mentions for Apollo Medical. ICF International's average media sentiment score of 0.88 beat Apollo Medical's score of 0.39 indicating that Apollo Medical is being referred to more favorably in the media.
ICF International has a net margin of 4.74% compared to ICF International's net margin of 3.56%. Apollo Medical's return on equity of 14.42% beat ICF International's return on equity.
Apollo Medical presently has a consensus target price of $47.20, indicating a potential upside of 15.63%. ICF International has a consensus target price of $162.75, indicating a potential upside of 15.61%. Given ICF International's stronger consensus rating and higher probable upside, research analysts plainly believe Apollo Medical is more favorable than ICF International.
ICF International received 207 more outperform votes than Apollo Medical when rated by MarketBeat users. Likewise, 67.38% of users gave ICF International an outperform vote while only 60.79% of users gave Apollo Medical an outperform vote.
Summary
ICF International beats Apollo Medical on 10 of the 18 factors compared between the two stocks.
Get ICF International News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICFI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICFI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ICF International Competitors List
Related Companies and Tools